Cutler Group LP Accelerate Diagnostics, Inc Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 26, 2021	BUY	$7.99 - $15.0 $2,397 - $4,500	300 New	300 $0
Q3 2020 Oct 27, 2020	SELL	$9.98 - $18.04 $2,994 - $5,412	-300 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$7.49 - $15.16 $2,247 - $4,548	300 New	300 $0
Q1 2020 May 07, 2020	SELL	$4.62 - $18.74 $23,100 - $93,699	-5,000 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$16.62 - $23.92 $69,804 - $100,464	4,200 Added 525.0%	5,000 $16,000
Q1 2018 May 11, 2018	SELL	$22.55 - $29.9 $243,540 - $322,920	-10,800 Reduced 93.1%	800 $0
Q4 2017 Jan 17, 2018	BUY	$18.0 - $30.0 $19,800 - $33,000	1,100 Added 10.48%	11,600 $16,000
Q3 2017 Oct 17, 2017	BUY	$21.1 - $25.15 $221,550 - $264,075	10,500	10,500 $13,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.